OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ASTRAZENECA PLC DL-,25/  GB0009895292  /

Frankfurt
2024-04-30  2:26:58 PM Chg. +1.0500 Volume Bid8:44:34 PM Ask8:41:45 PM Market Capitalization Dividend Y. P/E Ratio
142.5500EUR +0.74% 360
Turnover: 51,185		 140.9500Bid Size: 100 143.0000Ask Size: 400 218.7 bill.EUR - -
GlobeNewswire 1:00 PM CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical D...
GlobeNewswire 04-29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 03-28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 03-19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 03-18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 03-14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 03-14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 02-26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 02-22 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 02-22 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 02-20 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 02-09 Europe mostly lower premarket amid German CPI, earnings
TeleTrader 02-08 Europe closes mostly higher following earnings
TeleTrader 02-08 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 02-08 AstraZeneca's revenue in Q4 rises 5% to $11.3B
GlobeNewswire 02-05 Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire 02-02 BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire 01-10 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
Newsfile Corp 01-09 The World's 30 Best Places to Work for 2023 Revealed
GlobeNewswire 01-03 Use of SGLT2 Inhibitors Continues to Expand for the Treatment of Chronic Kidney Disease, with Eli Li...
TeleTrader 2023-12-27 US opens mostly flat ahead of jobs data